MedTrace Logo

Effect of Selenium Supplementation on Inflammatory,Oxidative and Nutritional Markers in Hemodialysis Patients

NCT01147354 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2012-02-02

No results posted yet for this study

Summary

The aim of this study is to evaluate the effect of selenium supplementation on oxidative, inflammatory and nutritional markers in hemodialysis patients.

Conditions

Interventions

DIETARY_SUPPLEMENT

selenium yeast

The patients in this arm took 200 micrograms of selenium yeast daily for 12 weeks.

OTHER

placebo capsules

The patients in this arm took one placebo capsule daily for 12 weeks.

Sponsors & Collaborators

  • Shiraz University of Medical Sciences

    collaborator OTHER

  • Zahra Sohrabi

    lead OTHER

Principal Investigators

  • Zahra Sohrabi, Ph.D · Shiraz University of Medical Sciences

  • Mohammad mahdi Sagheb, M.D · Shiraz University of Medical Sciences

  • Moosa Salehi, Ph.D · Shiraz University of Medical Sciences

  • Maryam Ekramzadeh, Ph.D · Shiraz University of Medical Sciences

  • Mohammad Kazem Fallahzadeh, M.D · Shiraz University of Medical Sciences

  • Maryam Ayatollahi, Ph.D · Shiraz University of Medical Sciences

  • Bita Geramizadeh, M.D · Shiraz University of Medical Sciences

  • Jafar Hassanzadeh, Ph.D · Shiraz University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2009-07-31
Completion
2009-09-30

Countries

  • Iran

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01147354 on ClinicalTrials.gov